Clinical Trial Update: A Trial Investigating NN1218 in Subjects With Type 1 and Type 2 Diabetes [Phase 1]

View source ↗

Summary

A Phase 1 trial of NN1218 in subjects with Type 1 and Type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• NN1218

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED